Australia's Zelira Therapeutics climbs to over 7-month high on securing patents

Zelira Therapeutics

16/07/2024 03:15

** Shares of Zelira Therapeutics  ZLD.AX  rise as much as
25% to A$1, their highest since Dec 4, 2023
    ** The biopharma co confirms it secured patents for HOPE 1
and HOPE 2 formulations from the Australian government's
Commission of Patents and the U.S. Patent and Trademark Office
    ** Co says these patents relate to drugs that are designed
to treat cluster symptoms associated with autism spectrum
disorder (ASD)
    ** About 17,101 shares change hands, 1.8 times the 30-day
average volume of shares
    ** Stock has fallen 11.11% this year, as of last close

 (Reporting by Sherin Sunny in Bengaluru)
 ((sherin.sunny@thomsonreuters.com))